Skip to main content
logo
Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
1.770
-0.085 (-4.58%)
Oct 7, 2026, 4:10 PM AEST

Racura Oncology Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
347434204311200311
Market Cap Growth
-49.71%112.66%-34.32%55.59%-35.78%-41.00%
Enterprise Value
313413185297173274
Last Close Price
1.772.221.181.821.231.95

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
123.46154.4438.8577.6363.73439.48
PB Ratio
9.5211.9112.7516.977.848.62
P/TBV Ratio
10.1512.7015.1420.058.929.50

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
111.26146.9935.2874.2155.32387.06

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.94-0.94-0.85-0.94-0.84-0.93
Net Debt / EBITDA Ratio
3.393.392.621.212.113.07
Net Debt / FCF Ratio
4.164.162.991.802.025.36
Asset Turnover
0.100.100.280.170.100.03
Quick Ratio
21.2821.289.429.2620.1623.71
Current Ratio
21.4321.4310.299.3220.4424.10
Return on Equity (ROE)
-42.27%-42.27%-27.89%-63.10%-32.22%-44.96%
Return on Assets (ROA)
-23.40%-23.40%-18.24%-38.63%-20.41%-27.05%
Return on Capital Employed (ROCE)
-28.50%-28.50%-34.30%-78.90%-41.10%-31.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-3.20%-2.55%-2.34%-4.45%-4.97%-3.60%
FCF Yield
-2.38%-1.90%-2.24%-3.07%-5.33%-2.01%
Buyback Yield / Dilution
-3.90%-3.90%-4.81%-2.35%-4.83%-17.06%